414P The complex relationship between circulating tumor cells (CTCs) and brain metastases (BMs) in metastatic breast cancer (mBC): A retrospective pooled analysis
B. Pastò(University of Udine), M. Cristofanilli(Cornell University), François‐Clément Bidard(Inserm), C. Reduzzi(Cornell University), Ángela Fernández de Lascoiti(Universidad de Navarra), F. Puglisi(University of Udine), C. Caldas(Cancer Research UK Cambridge Center), José Á. García-Sáenz(Hospital Clínico San Carlos), D. Generali(Azienda Socio Sanitaria Territoriale Lariana), Klaus Pantel(Universität Hamburg), Mario Giuliano(Regione Campania), S. Riethdorf(Universität Hamburg), Leticia De Mattos‐Arruda(Universitat Autònoma de Barcelona), Tanja Fehm(Düsseldorf University Hospital), W Janni(University Hospital Ulm), M. Ignatiadis(Institut Jules Bordet), J-Y Pierga(Institut Curie), L. Gerratana(University of Udine), EF Solomayer(Saarland University), P. Gazzaniga(Sapienza University of Rome)
Cited by 1
Related Papers
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
|Journal of Clinical Oncology|2022|676
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
|British Journal of Cancer|2020|402
Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells
|Developmental Cell|2018|328